Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.
Novo Nordisk shares jump 7% as drugmaker sees copycat Wegovy sales easing in 2025
by Elite Financial Group | May 7, 2025 | Breaking News